Small Molecule Adjuvants Potentiate Colistin Activity and Attenuate Resistance Development in Escherichia coli by Affecting pmrAB System

References

• Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. Int J Antimicrob Agents. 2016;48(6):598–606. doi:10.1016/j.ijantimicag.2016.09.01627836380
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557. doi:10.1128/CMR.00064-1628275006
   PubMed Web of Science ®Google Scholar
• Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther. 2012;10(8):917–934. doi:10.1586/eri.12.7823030331
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J-H. Monitoring colistin resistance in food animals, an urgent threat. Expert Rev Anti Infect Ther. 2018;16(6):443–446. doi:10.1080/14787210.2018.148174929865881
   PubMed Web of Science ®Google Scholar
• Landman WJM, van Eck JHH. The incidence and economic impact of the Escherichia coli peritonitis syndrome in Dutch poultry farming. Avian Pathol. 2015;44(5):370–378. doi:10.1080/03079457.2015.106058426083823
   PubMed Web of Science ®Google Scholar
• Le Devendec L, Mourand G, Bougeard S, et al. Impact of colistin sulfate treatment of broilers on the presence of resistant bacteria and resistance genes in stored or composted manure. Vet Microbiol. 2016;194:98–106. doi:10.1016/j.vetmic.2015.11.01226616601
   PubMed Web of Science ®Google Scholar
• Baron S, Hadjadj L, Rolain J-M, Olaitan AO. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int J Antimicrob Agents. 2016;48(6):583–591. doi:10.1016/j.ijantimicag.2016.06.02327524102
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Huang X, Yu L, Chen X, et al. High prevalence of colistin resistance and mcr-1 gene in Escherichia coli isolated from food animals in China. Front Microbiol. 2017;8:562. doi:10.3389/fmicb.2017.0056228421056
   PubMed Web of Science ®Google Scholar
• Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M. Identification of novel mobilized colistin resistance gene mcr-9 in a multidrug-resistant, colistin-susceptible Salmonella enterica serotype typhimurium isolate. mBio. 2019;10(3):e00853–00819. doi:10.1128/mBio.00853-1931064835
   PubMed Web of Science ®Google Scholar
• Elbediwi M, Li Y, Paudyal N, et al. Global burden of colistin-resistant bacteria: mobilized colistin resistance genes study (1980–2018). Microorganisms. 2019;7(10):10. doi:10.3390/microorganisms7100461
   Web of Science ®Google Scholar
• MacNair CR, Stokes JM, Carfrae LA, et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun. 2018;9(1):458. doi:10.1038/s41467-018-02875-z29386620
   PubMed Web of Science ®Google Scholar
• Minrovic BM, Jung D, Melander RJ, Melander C. New class of adjuvants enables lower dosing of colistin against Acinetobacter baumannii. ACS Infect Dis. 2018;4(9):1368–1376. doi:10.1021/acsinfecdis.8b0010329890069
   PubMed Web of Science ®Google Scholar
• Bernal P, Molina-Santiago C, Daddaoua A, Llamas MA. Antibiotic adjuvants: identification and clinical use. Microb Biotechnol. 2013;6(5):445–449. doi:10.1111/1751-7915.1204423445397
   PubMed Web of Science ®Google Scholar
• Kubo A, Lunde CS, Kubo I. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli. Antimicrob Agents Chemother. 1996;40(6):1438–1441. doi:10.1128/AAC.40.6.14388726016
   PubMed Web of Science ®Google Scholar
• Pollini S, Boncompagni S, Di Maggio T, et al. In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. J Antimicrob Chemother. 2018;73(9):2388–2395. doi:10.1093/jac/dky18529846610
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Principato S, Colavecchio OL, Pallecchi L, Rossolini GM. Synergistic activity of colistin in combination with resveratrol against colistin-resistant gram-negative pathogens. Front Microbiol. 2018;9:1808. doi:10.3389/fmicb.2018.0180830131787
   PubMed Web of Science ®Google Scholar
• Domalaon R, De Silva PM, Kumar A, Zhanel GG, Schweizer F. The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in gram-negative bacilli. Antimicrob Agents Chemother. 2019;63(4):4. doi:10.1128/AAC.02574-18
   Web of Science ®Google Scholar
• Stokes JM, MacNair CR, Ilyas B, et al. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nature Microbiol. 2017;2(5):17028. doi:10.1038/nmicrobiol.2017.2828263303
   PubMed Web of Science ®Google Scholar
• Harris TL, Worthington RJ, Hittle LE, Zurawski DV, Ernst RK, Melander C. Small molecule downregulation of pmrAB reverses lipid A modification and breaks colistin resistance. ACS Chem Biol. 2014;9(1):122–127. doi:10.1021/cb400490k24131198
   PubMed Web of Science ®Google Scholar
• Wang YM, Kong LC, Liu J, Ma HX. Synergistic effect of eugenol with Colistin against clinical isolated Colistin-resistant Escherichia coli strains. Antimicrob Resist Infect Control. 2018;7(1):17. doi:10.1186/s13756-018-0303-729423192
   PubMed Web of Science ®Google Scholar
• Barker WT, Martin SE, Chandler CE, et al. Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria. Bioorg Med Chem. 2017;25(20):5749–5753. doi:10.1016/j.bmc.2017.08.05528958847
   PubMed Web of Science ®Google Scholar
• Kathayat D, Helmy YA, Deblais L, Rajashekara G. Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli. Sci Rep. 2018;8(1):15329. doi:10.1038/s41598-018-33587-530333507
   PubMed Web of Science ®Google Scholar
• Galani I, Orlandou K, Moraitou H, Petrikkos G, Souli M. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2014;43(4):370–374. doi:10.1016/j.ijantimicag.2013.12.01024560919
   PubMed Web of Science ®Google Scholar
• Morroni G, Simonetti O, Brenciani A, et al. In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds. Med Microbiol Immunol. 2019;208(6):877–883. doi:10.1007/s00430-019-00624-731214759
   PubMed Web of Science ®Google Scholar
• Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. BMC Microbiol. 2019;19(1):54. doi:10.1186/s12866-019-1416-830849936
   PubMed Web of Science ®Google Scholar
• Torres NS, Montelongo-Jauregui D, Abercrombie JJ, et al. Antimicrobial and antibiofilm activity of synergistic combinations of a commercially available small compound library with colistin against Pseudomonas aeruginosa. Front Microbiol. 2018;9:2541. doi:10.3389/fmicb.2018.0254130410476
   PubMed Web of Science ®Google Scholar
• Johnson TJ, Wannemuehler Y, Doetkott C, Johnson SJ, Rosenberger SC, Nolan LK. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol. 2008;46(12):3987–3996. doi:10.1128/JCM.00816-0818842938
   PubMed Web of Science ®Google Scholar
• Guabiraba R, Schouler C. Avian colibacillosis: still many black holes. FEMS Microbiol Lett. 2015;362(15):fnv118–fnv118. doi:10.1093/femsle/fnv11826204893
   PubMed Web of Science ®Google Scholar
• Liu CM, Stegger M, Aziz M, et al. Escherichia coli ST131- H 22 as a foodborne uropathogen. mBio. 2018;9(4):4. doi:10.1128/mBio.00470-18
   Web of Science ®Google Scholar
• Osman KM, Kappell AD, Elhadidy M, et al. Poultry hatcheries as potential reservoirs for antimicrobial-resistant Escherichia coli: a risk to public health and food safety. Sci Rep. 2018;8(1):5859. doi:10.1038/s41598-018-23962-729643424
   PubMed Web of Science ®Google Scholar
• Baym M, Stone LK, Kishony R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science. 2016;351(6268):aad3292–aad3292. doi:10.1126/science.aad329226722002
   PubMed Web of Science ®Google Scholar
• Wallace Iain M, Urbanus Malene L, Luciani Genna M, et al. Compound prioritization methods increase rates of chemical probe discovery in model organisms. Chem Biol. 2011;18(10):1273–1283. doi:10.1016/j.chembiol.2011.07.01822035796
   PubMedGoogle Scholar
• CLSI.. Performance Standards for Antimicrobial Susceptibility Testing. 28th CLSI supplement M100 Wayne, PA: Clinical and Laboratory Standards Institute; 2018
   Google Scholar
• Orhan G, Bayram A, Zer Y, Balci I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005;43(1):140–143. doi:10.1128/JCM.43.1.140-143.200515634962
   PubMed Web of Science ®Google Scholar
• Deblais L, Helmy YA, Kathayat D, Huang H-C, Miller SA, Rajashekara G. Novel imidazole and methoxybenzylamine growth inhibitors affecting salmonella cell envelope integrity and its persistence in chickens. Sci Rep. 2018;8(1):13381. doi:10.1038/s41598-018-31249-030190570
   PubMed Web of Science ®Google Scholar
• Bremmer DN, Bauer KA, Pouch SM, et al. Correlation of checkerboard synergy testing with time-kill analysis and clinical outcomes of extensively drug-resistant Acinetobacter baumannii respiratory infections. Antimicrob Agents Chemother. 2016;60(11):6892–6895. doi:10.1128/AAC.00981-1627527089
   PubMed Web of Science ®Google Scholar
• Betts J, Nagel C, Schatzschneider U, Poole R, La Ragione RM. Antimicrobial activity of carbon monoxide-releasing molecule [Mn(CO)(3)(tpa-κ(3)N)]Br versus multidrug-resistant isolates of Avian Pathogenic Escherichia coli and its synergy with colistin. PLoS One. 2017;12(10):e0186359. doi:10.1371/journal.pone.018635929040287
   PubMed Web of Science ®Google Scholar
• Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother. 2009;53(6):2605. doi:10.1128/AAC.01533-0819332683
   PubMed Web of Science ®Google Scholar
• Tsai CJ-Y, Loh JMS, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229. doi:10.1080/21505594.2015.113528926730990
   PubMed Web of Science ®Google Scholar
• Lázár V, Martins A, Spohn R, et al. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nature Microbiol. 2018;3(6):718–731. doi:10.1038/s41564-018-0164-029795541
   PubMed Web of Science ®Google Scholar
• Zankari E, Allesoe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764–2768. doi:10.1093/jac/dkx21729091202
   PubMed Web of Science ®Google Scholar
• Altshuler D, Pollara VJ, Cowles CR, et al. An SNP map of the human genome generated by reduced representation shotgun sequencing. Nature. 2000;407(6803):513–516. doi:10.1038/3503508311029002
   PubMed Web of Science ®Google Scholar
• Brockman W, Alvarez P, Young S, et al. Quality scores and SNP detection in sequencing-by-synthesis systems. Genome Res. 2008;18(5):763–770. doi:10.1101/gr.070227.10718212088
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Di Pilato V, Giani T, et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother. 2014;58(8):4399–4403. doi:10.1128/AAC.02555-1424841267
   PubMed Web of Science ®Google Scholar
• Helmy YA, Deblais L, Kassem II, Kathayat D, Rajashekara G. Novel small molecule modulators of quorum sensing in avian pathogenic Escherichia coli (APEC). Virulence. 2018;9(1):1640–1657. doi:10.1080/21505594.2018.152884430270715
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Giani T, Aiezza N, et al. An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin. Sci Rep. 2017;7(1):5071. doi:10.1038/s41598-017-05167-628698568
   PubMed Web of Science ®Google Scholar
• Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17(3):141–155. doi:10.1038/s41579-018-0141-x30683887
   PubMed Web of Science ®Google Scholar
• Mingeot-Leclercq M-P, Decout J-L. Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. MedChemComm. 2016;7(4):586–611. doi:10.1039/C5MD00503E
   Web of Science ®Google Scholar
• Stowe SD, Thompson RJ, Peng L, et al. Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii. Curr Drug Deliv. 2015;12(2):223–230. doi:10.2174/156720181166614092412574025348099
   PubMed Web of Science ®Google Scholar
• Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–2747. doi:10.1093/bioinformatics/btv19525851949
   PubMed Web of Science ®Google Scholar
• Sato T, Shiraishi T, Hiyama Y, et al. Contribution of novel amino acid alterations in pmrA or pmrB to Colistin resistance in mcr-negative Escherichia coli clinical isolates, including major multidrug-resistant lineages O25b:H4-ST131- H 30Rx and Non-x. Antimicrob Agents Chemother. 2018;62(9):9. doi:10.1128/AAC.00864-18
   Web of Science ®Google Scholar
• Luo Q, Yu W, Zhou K, et al. Molecular epidemiology and colistin resistant mechanism of mcr-positive and mcr-negative clinical isolated Escherichia coli. Front Microbiol. 2017;8:2262. doi:10.3389/fmicb.2017.0226229250039
   PubMed Web of Science ®Google Scholar
• Delannoy S, Le Devendec L, Jouy E, Fach P, Drider D, Kempf I. Characterization of colistin-resistant Escherichia coli isolated from diseased pigs in France. Front Microbiol. 2017;8:2278. doi:10.3389/fmicb.2017.0227829209292
   PubMed Web of Science ®Google Scholar
• Quesada A, Porrero MC, Téllez S, Palomo G, García M, Domínguez L. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. J Antimicrob Chemother. 2014;70(1):71–74. doi:10.1093/jac/dku32025150146
   PubMed Web of Science ®Google Scholar
• Bourrel AS, Poirel L, Royer G, et al. Colistin resistance in Parisian inpatient faecal Escherichia coli as the result of two distinct evolutionary pathways. J Antimicrob Chemother. 2019;74(6):1521–1530. doi:10.1093/jac/dkz09030863849
   PubMed Web of Science ®Google Scholar
• Rebelo AR, Bortolaia V, Kjeldgaard JS, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Eurosurveillance. 2018;23(6):17–00672. doi:10.2807/1560-7917.ES.2018.23.6.17-00672
   Web of Science ®Google Scholar
• Vounba P, Rhouma M, Arsenault J, Bada Alambédji R, Fravalo P, Fairbrother JM. Prevalence of colistin resistance and mcr-1/mcr-2 genes in extended-spectrum β-lactamase/AmpC-producing Escherichia coli isolated from chickens in Canada, Senegal and Vietnam. J Glob Antimicrob Resist. 2019;19:222–227. doi:10.1016/j.jgar.2019.05.00231100501
   PubMed Web of Science ®Google Scholar
• Cafiso V, Stracquadanio S, Lo Verde F, et al. Colistin resistant A. baumannii: genomic and transcriptomic traits acquired under colistin therapy. Front Microbiol. 2019;9:3195. doi:10.3389/fmicb.2018.0319530666237
   PubMed Web of Science ®Google Scholar
• Wright MS, Suzuki Y, Jones MB, et al. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother. 2015;59(1):536–543. doi:10.1128/AAC.04037-1425385117
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Na IY, Park YK, Ko KS. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance. J Antimicrob Chemother. 2014;69(5):1248–1256. doi:10.1093/jac/dkt53124474431
   PubMed Web of Science ®Google Scholar
• Mehta HH, Prater AG, Beabout K, et al. The essential role of hypermutation in rapid adaptation to antibiotic stress. Antimicrob Agents Chemother. 2019;63(7):e00744–00719. doi:10.1128/AAC.00744-1931036684
   PubMed Web of Science ®Google Scholar